All Stories

  1. Immersive Technologies for Cognitive Rehabilitation in Dementia and Mild Cognitive Impairment: Systematic Review
  2. Neuropsychiatric and behavioural correlates of sundowning in Alzheimer’s disease
  3. Repetitive Transcranial Magnetic Stimulation for Spasticity in Stroke and Other Neuromotor Disorders: A Systematic Review of Randomized Clinical Trials
  4. Impaired interhemispheric inhibition in isolated REM sleep Behavior Disorder: first exploratory Transcranial Magnetic Stimulation-based evidence
  5. Transcranial Magnetic Stimulation in Parkinson’s Disease and Parkinsonian Syndromes: A Narrative Expert Review
  6. Dysregulation of miRNAs in Sicilian Patients with Autism Spectrum Disorder
  7. Anxiety-Related Functional Dizziness: A Systematic Review of the Recent Evidence on Vestibular, Cognitive Behavioral, and Integrative Therapies
  8. Transcranial Magnetic Stimulation in Parkinson’s Disease and Parkinsonian Syndromes: A “State-of-Art” Perspective
  9. Transcranial doppler detected right-to-left shunt is common but not associated with MRI white matter hyperintensity burden: a cross-sectional study
  10. Epigenetic Signatures in an Italian Cohort of Parkinson’s Disease Patients from Sicily
  11. Beyond the Sleep Lab: A Narrative Review of Wearable Sleep Monitoring
  12. Periodic limb movements during sleep and progression of sleep apnea: a longitudinal analysis from the Wisconsin sleep cohort
  13. Antidepressant and Related Neurobiological and Neurophysiological Effects of Add-On Transcranial Direct Current Stimulation in Major Depressive Disorder with Residual Symptoms: A Randomized, Double-Blind Clinical Trial Protocol
  14. Dysregulation of miRNAs in Sicilian Patients with Huntington’s Disease
  15. Exploring the Role of Ferroptosis in the Pathophysiology and Circadian Regulation of Restless Legs Syndrome
  16. Odontophobia Across the Lifespan: Clinical Perspectives, Vulnerable Populations, and Inclusive Strategies for Dental Anxiety Management
  17. Protein Expression of TXNIP in the Dopaminergic Neurons of Subjects with Parkinson’s Disease: Evidence from a Pilot Study
  18. Autonomic correlates of large muscle group movements during non-REM sleep in restless legs syndrome: a comparative analysis with periodic and non-periodic leg movements
  19. Management and Treatment of Carotid Stenosis: Overview of Therapeutic Possibilities and Comparison Between Interventional Radiology, Surgery and Hybrid Procedure
  20. Alteration of Metabolic Profile in Patients with Narcolepsy Type 1
  21. Moving beyond muscle atonia: rapid eye movement sleep microstructure as a biomarker in sleep behavior disorder
  22. Sex differences in cerebrospinal fluid proteomics of patients with restless legs syndrome
  23. Neuroprotective effects of rTMS in chronic insomnia: is glymphatic system modulation the key player?
  24. Transcriptome Study in Sicilian Patients with Huntington’s Disease
  25. Strengthening the link between periodic leg movements during sleep and cerebral small vessel disease
  26. Chronotype and Cancer: Emerging Relation Between Chrononutrition and Oncology from Human Studies
  27. Evidence of Involvement of the Calcitonin Gene‐Related Peptide in Restless Legs Syndrome
  28. Transcranial Doppler sonography follow-up study in mild vascular cognitive impairment
  29. Evaluating the differential effects of dopamine agonists and clonazepam on large muscle group movements in restless legs syndrome
  30. Event-related potentials as neurophysiological predictors of high-risk isolated REM sleep behavior disorder patients
  31. Unraveling the pathophysiology of restless legs syndrome from multimodal MRI techniques: A systematic review
  32. Sleep and sleep disorders
  33. Age‐related changes in large muscle group movements during sleep
  34. The Role of ETNPPL in Dopaminergic Neuron Stability: Insights from Neuromelanin-Associated Protein Expression in Parkinson’s Disease
  35. Intersection of Sleep Disorders and Parkinson Disease: Unveiling the Bidirectional Relationship
  36. Exploring sex differences in periodic leg movements during sleep across the lifespan of patients with restless legs syndrome
  37. Response to iron supplementation is similar between boys and girls with pediatric sleep movement disorders
  38. The Fascinating Link between Psychedelics and Neuroplasticity
  39. Combined Effect of Red Wine and Mocha Pot Coffee in Mild Vascular Cognitive Impairment
  40. Sex‐based disparities in dopamine agonist response in patients with restless legs syndrome
  41. Sensory aspects of restless legs syndrome: Clinical, neurophysiological and neuroimaging prospectives
  42. The Triad of Sleep, Immunity, and Cancer: A Mediating Perspective
  43. Transcriptome Study in Sicilian Patients with Autism Spectrum Disorder
  44. The dynamics of cyclic‐periodic phenomena during non‐rapid and rapid eye movement sleep
  45. Large muscle group movements during sleep in restless leg syndrome: neurophysiological and clinical implications
  46. Targeting the adenosinergic system in restless legs syndrome: A pilot, “proof-of-concept” placebo-controlled TMS-based protocol
  47. A survey-based approach on restless legs syndrome: practices and perspectives among Italian neurologists
  48. Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis
  49. A narrative review on insomnia and hypersomnolence within Major Depressive Disorder and bipolar disorder: A proposal for a novel psychometric protocol
  50. Changes in time structure of periodic leg movements during sleep in restless legs syndrome: Effects of sex and age
  51. Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members
  52. Relation between dietary inflammatory potential and sleep features: Systematic review of observational studies
  53. Setting research priorities for global pandemic preparedness: An international consensus and comparison with ChatGPT’s output
  54. A Topical Review on Transcranial Magnetic Stimulation in Restless Legs Syndrome
  55. Polysomnographic features associated with clonazepam and melatonin treatment in isolated REM sleep behavior disorder: Time for new therapeutic approaches?
  56. Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis
  57. Mediterranean Diet and Sleep Features: A Systematic Review of Current Evidence
  58. Pain-Free Alpha-Synuclein Detection by Low-Cost Hierarchical Nanowire Based Electrode
  59. Gene Expression Profiling of Post Mortem Midbrain of Parkinson’s Disease Patients and Healthy Controls
  60. REHASTART: Cognitive Tele-Rehabilitation Empowered by Vision Transformers
  61. Transcriptome Analysis in Patients With Muscle-invasive Bladder Cancer
  62. COVID‐19 and Mental Health: A “Pandemic Within a Pandemic”
  63. Interdisciplinary Multidimensional Assessment of Transthyretin Amyloidosis before and after Tafamidis
  64. Editorial: Application of noninvasive neuromodulation in cognitive rehabilitation
  65. A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson’s Disease
  66. Transcranial Magnetic Stimulation for the Treatment of Gambling Disorder: A Systematic Review
  67. Psychophysiology of Sleep
  68. Gene Expression Profiling of Post Mortem midbrain of Parkinson’s Disease patients and Healthy Controls
  69. Neuroanatomical findings in isolated REM sleep behavior disorder and early Parkinson’s disease: a Voxel-based morphometry study
  70. “Mind” versus “Body” in Mild Cognitive Impairment Rehabilitation: Does a Multicomponent Physical Exercise Program Have a Dichotomous Effect on Cognitive Functions and Physical Performance?
  71. Mediterranean diet and chronotype: Data from Italian adults and systematic review of observational studies
  72. Special Issue “Sleep Disorders: From Clinical Research to Daily Practice”
  73. Sex-specific reference values for total, central, and peripheral latency of motor evoked potentials from a large cohort
  74. Editorial: Nutrients and brain: from bench to the bedside
  75. Considering REM Sleep Behavior Disorder in the Management of Parkinson’s Disease
  76. ESOC 2023 Abstract Book
  77. Mediterranean diet, mental health, cognitive status, quality of life, and successful aging in southern Italian older adults
  78. The Y831C Mutation of the POLG Gene in Dementia
  79. Severity of REM sleep without atonia correlates with measures of cognitive impairment and depressive symptoms in REM sleep behaviour disorder
  80. Reply: Post‐COVID‐19 Myoclonus‐Ataxia Syndrome—Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?
  81. Challenging the Pleiotropic Effects of Repetitive Transcranial Magnetic Stimulation in Geriatric Depression: A Multimodal Case Series Study
  82. Dietary Fats and Cognitive Status in Italian Middle-Old Adults
  83. Sleep counts! Role and impact of sleep in the multimodal management of multiple sclerosis
  84. Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
  85. Sex differences in mild vascular cognitive impairment: A multimodal transcranial magnetic stimulation study
  86. Central and Peripheral Nervous System Complications of Vasculitis Syndromes from Pathology to Bedside: Part 2—Peripheral Nervous System
  87. Neurobiology and Applications of Inositol in Psychiatry: A Narrative Review
  88. Repetitive transcranial magnetic stimulation in primary sleep disorders
  89. Dietary Fats and Depressive Symptoms in Italian Adults
  90. Transcranial magnetic stimulation for the treatment of gambling disorder (GD): a systematic review
  91. Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
  92. The supporting (sometimes decisive!) role of transcranial magnetic stimulation in forensic medicine
  93. Role and Dysregulation of miRNA in Patients with Parkinson’s Disease
  94. Endothelial Reprogramming in Sports Traumatology: Role of the Widespread Neuro-Immuno-Endocrine-Endothelial System
  95. Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation
  96. Abstracts of the 52nd Annual Conference of the Italian Society of Neurology
  97. Diabetic Striatopathy: Parenchymal Transcranial Sonography as a Supplement to Diagnosis at the Emergency Department
  98. Acute Cerebellar Ataxia and Myoclonus in SARS‐CoV ‐2–Related Encephalopathy Responsive to Immunotherapy: A Case Series
  99. PC012 / #460 MULTIMODAL EFFECTS OF REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION ON PATIENTS WITH MAJOR DEPRESSION AND VASCULAR DEPRESSION: A PILOT STUDY
  100. A comprehensive review of transcranial magnetic stimulation in secondary dementia
  101. Cerebral hemodynamic changes to transcranial Doppler sonography in celiac disease: A pilot study
  102. Post–COVID‐19 Myoclonus–Ataxia Syndrome Responsive to Intravenous Immunoglobulins
  103. TU-225. Electrocortical overlap between isolated RBD and Parkinson’s disease with RBD: A pilot TMS study
  104. A Systematic Review on the Effect of Nutraceuticals on Antidepressant-Induced Sexual Dysfunctions: From Basic Principles to Clinical Applications
  105. Repetitive transcranial magnetic stimulation for post-traumatic stress disorder: Lights and shadows
  106. Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA
  107. Fabry’s Disease: The Utility of a Multidisciplinary Screening Approach
  108. Reduced Intracortical Facilitation to TMS in Both Isolated REM Sleep Behavior Disorder (RBD) and Early Parkinson’s Disease with RBD
  109. Research priorities to reduce the impact of COVID-19 in low- and middle-income countries
  110. Neurological Presentation of Giant Pituitary Tumour Apoplexy: Case Report and Literature Review of a Rare but Life-Threatening Condition
  111. Daily mocha coffee intake and psycho-cognitive status in non-demented non-smokers subjects with subcortical ischaemic vascular disease
  112. Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer’s Disease
  113. A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson’s Disease
  114. Post-stroke aphasia at the time of COVID-19 pandemic: a telerehabilitation perspective
  115. Sleep and homeostatic control of plasticity
  116. Central and Peripheral Nervous System Complications of Vasculitis Syndromes From Pathology to Bedside: Part 1—Central Nervous System
  117. Preserved central cholinergic functioning to transcranial magnetic stimulation in de novo patients with celiac disease
  118. Morphological analysis of the brain subcortical gray structures in restless legs syndrome
  119. Objective and quantitative evaluation of fetal hiccups by computerized cardiotocography: a prospective observational study
  120. Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review
  121. Increased Serum Prolactin and Excessive Daytime Sleepiness: An Attempt of Proof-of-Concept Study
  122. A Review on P300 in Obsessive-Compulsive Disorder
  123. Impact of COVID-19 pandemic on the neuropsychiatric status of Wilson’s disease
  124. Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia
  125. Transcallosal motor disinhibition to transcranial magnetic stimulation in de novo patients with Celiac disease
  126. Transcranial doppler ultrasonography study in migraine patients treated with erenumab
  127. Late Breaking Abstracts
  128. Editorial: Non-invasive Brain Stimulation in the Study and Modulation of Metaplasticity in Neurological Disorders
  129. Cognitive Impairment in Inpatients with Prurigo Nodularis and Psychiatric Comorbidities
  130. Intracortical and Intercortical Motor Disinhibition to Transcranial Magnetic Stimulation in Newly Diagnosed Celiac Disease Patients
  131. An unusual gait disorder at the Emergency Department: role of the quantitative assessment of parenchymal transcranial Doppler sonography
  132. MMN in BD
  133. mRNA expression profiling of mitochondrial subunits in subjects with Parkinson’s disease
  134. Moderate Mocha Coffee Consumption Is Associated with Higher Cognitive and Mood Status in a Non-Demented Elderly Population with Subcortical Ischemic Vascular Disease
  135. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective
  136. Hypertensive Crisis in Acute Cerebrovascular Diseases Presenting at the Emergency Department: A Narrative Review
  137. Repetitive TMS for the “cognitive tsunami” of sleep deprivation
  138. Clinical and Electrophysiological Hints to TMS in De Novo Patients with Parkinson’s Disease and Progressive Supranuclear Palsy
  139. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19
  140. Abstracts of the 51st Annual Conference of the Italian Society of Neurology
  141. TMS Correlates of Pyramidal Tract Signs and Clinical Motor Status in Patients with Cervical Spondylotic Myelopathy
  142. Evaluation and Treatment of Vascular Cognitive Impairment by Transcranial Magnetic Stimulation
  143. Hepatitis C Virus Infection Increases Fatigue in Health Care Workers
  144. Screening for Fabry Disease in Kidney Transplant Recipients: Experience of a Multidisciplinary Team
  145. A Customized Next-Generation Sequencing-Based Panel to Identify Novel Genetic Variants in Dementing Disorders: A Pilot Study
  146. Cerebral Hemodynamic Changes to Transcranial Doppler in Asymptomatic Patients with Fabry’s Disease
  147. SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms
  148. Repetitive TMS for sleep disorders: are we ready?
  149. The present and the future of Transcranial Magnetic Stimulation in Restless Legs Syndrome
  150. Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis patients
  151. Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update
  152. ePoster Sessions
  153. Late-onset oro-facial dyskinesia in Spinocerebellar Ataxia type 2: a case report
  154. Update on the Neurobiology of Vascular Cognitive Impairment: From Lab to Clinic
  155. P21 TMS correlates of pyramidal signs and clinical motor status: Insights from a spinal perspective
  156. “Self-Neuroenhancement”: The Last Frontier of Noninvasive Brain Stimulation?
  157. The added value of parenchymal transcranial Doppler sonography at the Emergency Room: case report of an unusual gait disorder
  158. The added value of parenchymal transcranial Doppler sonography at the Emergency Room: case report of an unusual gait disorder
  159. “Mute” plantar response: does the cortico-spinal tract “speak”?
  160. Motor activity and Becker’s muscular dystrophy: lights and shadows
  161. Decrease in Serum Vitamin D Level of Older Patients with Fatigue
  162. Facilitatory/inhibitory intracortical imbalance in REM sleep behavior disorder: early electrophysiological marker of neurodegeneration?
  163. Migrainous Infarction And Cerebral Vasospasm: Case Report And Literature Review
  164. Invited Faculty Abstracts from the International Neuromodulation Society’s 14th World Congress
  165. A Customized NGS-Based Resequencing Gene Panel to Identify Genetic Variants in Dementing Disorders: Preliminary Results
  166. Update on intensive motor training in spinocerebellar ataxia: time to move a step forward?
  167. Adjunct Diagnostic Value of Transcranial Magnetic Stimulation in Mucopolysaccharidosis-Related Cervical Myelopathy: A Pilot Study
  168. Fear and disgust: case report of two uncommon emotional disturbances evoked by visual disperceptions after a right temporal-insular stroke
  169. Fear and disgust: case report of two uncommon emotional disturbances evoked by visual disperceptions after a right temporal-insular stroke
  170. Diagnostic and Prognostic Value of Transcranial Magnetic Stimulation in Mucopolysaccharidosis-Related Cervical Myelopathy
  171. Age, Height, and Sex on Motor Evoked Potentials: Translational Data From a Large Italian Cohort in a Clinical Environment
  172. Transcranial Doppler ultrasound in vascular cognitive impairment-no dementia
  173. Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain
  174. Clinical and neuroplastic effect of inhibitory rTMS on the sensory-motor cortical areas in RLS: a proof of concept study
  175. Fear and disgust: case report of two uncommon emotional disturbances evoked by visual disperceptions after a right temporal-insular stroke
  176. Interpreting Genetic Variants: Hints from a Family Cluster of Parkinson’s Disease
  177. Comment on “Shiatsu as an Adjuvant Therapy for Depression in Patients With Alzheimer’s Disease: A Pilot Study”
  178. Large expert-curated database for benchmarking document
  179. Repetitive transcranial magnetic stimulation in stroke rehabilitation: review of the current evidence and pitfalls
  180. The neurophysiology of hyperarousal in restless legs syndrome: Hints for a role of glutamate/GABA
  181. Cognitive Impairment and Celiac Disease: Is Transcranial Magnetic Stimulation a Trait d’Union between Gut and Brain?
  182. Impaired Cerebral Haemodynamics in Vascular Depression: Insights From Transcranial Doppler Ultrasonography
  183. Impaired short-term plasticity in restless legs syndrome: a pilot rTMS study
  184. Shiatsu as an adjuvant therapy for depression in patients with Alzheimer’s disease: A pilot study
  185. Early-onset subcortical ischemic vascular dementia in an adult with mtDNA mutation 3316G>A
  186. Clinical and electrophysiological impact of repetitive low-frequency transcranial magnetic stimulation on the sensory–motor network in patients with restless legs syndrome
  187. Motor and Perceptual Recovery in Adult Patients with Mild Intellectual Disability
  188. Neurophysiology of the “Celiac Brain”: Disentangling Gut-Brain Connections
  189. Nerve Conduction Studies as a Measure of Disease Progression: Objectivity or Illusion?
  190. Cortical Plasticity in Depression
  191. Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report
  192. Cortical involvement in celiac disease before and after long-term gluten-free diet: A Transcranial Magnetic Stimulation study
  193. Central and peripheral nervous system excitability in restless legs syndrome
  194. Impaired rTMS-induced short-term neuroplasticity in restless legs syndrome: a pilot study
  195. P008 Long term neurophysiological effects of the gluten-free diet in adult celiac patients: A TMS study
  196. Prominent neurological involvement in Dercum disease
  197. Retroclival subdural hematoma after a lumbar puncture: An uncommon complication for a common procedure
  198. Unusual Neurological Presentation of Nevoid Basal Cell Carcinoma Syndrome (Gorlin-Goltz Syndrome)
  199. Vascular Cognitive Impairment through the Looking Glass of Transcranial Magnetic Stimulation
  200. The impact of drugs for multiple sclerosis on sleep
  201. Response to the letter to the editor “Cortical excitability in restless legs syndrome”
  202. Cholinergic circuitry functioning in patients with vascular cognitive impairment – no dementia
  203. Correlation between Motor Cortex Excitability Changes and Cognitive Impairment in Vascular Depression: Pathophysiological Insights from a Longitudinal TMS Study
  204. European Stroke Conference. 25th Conference, Venice, Italy, April 13-15, 2016: Abstract e-Book
  205. Effects of the modulation of sensory or motor cortical excitability by rTMS in restless legs syndrome
  206. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study
  207. Acute Isolated Trochlear Nerve Palsy in a Patient with Cavernous Carotid Aneurysm and Visit-to-Visit Variability in Systolic Blood Pressure
  208. Effect of a Gluten-Free Diet on Cortical Excitability in Adults with Celiac Disease
  209. Poster Presentation with Discussion
  210. Motor cortex plasticity in subcortical ischemic vascular dementia: What can TMS say?
  211. Distinctive patterns of cortical excitability to transcranial magnetic stimulation in obstructive sleep apnea syndrome, restless legs syndrome, insomnia, and sleep deprivation
  212. Direct comparison of cortical excitability to transcranial magnetic stimulation in obstructive sleep apnea syndrome and restless legs syndrome
  213. Excitability of the Motor Cortex in De Novo Patients with Celiac Disease
  214. Epileptic Seizure as a Precipitating Factor of Vascular Progressive Supranuclear Palsy: A Case Report
  215. Different patterns of cortical excitability in major depression and vascular depression: a transcranial magnetic stimulation study
  216. P.2.h.003 Transcranial magnetic stimulation in major depression and vascular depression
  217. Transcranial Magnetic Stimulation in the Assessment of Motor Cortex Excitability and Treatment of Drug-Resistant Major Depression
  218. P.4.027 Six-month follow-up study of repetitive transcranial magnetic stimulation in the treatment of resistant major depressive disorder
  219. TMS follow-up study in patients with vascular cognitive impairment-no dementia
  220. Course of Atypical Manifestations of a Case of Charcot-Marie-Tooth Disease over 35 Years of Clinical Observation
  221. Preserved Transcallosal Inhibition to Transcranial Magnetic Stimulation in Nondemented Elderly Patients with Leukoaraiosis
  222. Focal neurological deficit in acute anemia: Case reports and review of the literature
  223. P.2.c.029 Repetitive transcranial magnetic stimulation and pharmacological treatment in patients with major depressive disorder
  224. Phenotypic heterogeneity in hereditary motor neuropathy type V: a new case report series
  225. Performance Evaluation of Classifiers in Distinguishing Mental Tasks from EEG Signals
  226. Motor cortex excitability in vascular depression
  227. Enhanced motor cortex facilitation in patients with vascular cognitive impairment-no dementia
  228. Transcranial magnetic stimulation in Alzheimer’s disease: a neurophysiological marker of cortical hyperexcitability
  229. A Review of Transcranial Magnetic Stimulation in Vascular Dementia
  230. An Interactive Tool for Customizing Clinical Transacranial Magnetic Stimulation (TMS) Experiments
  231. Clinical Presentation and Outcome of Geriatric Depression in Subcortical Ischemic Vascular Disease